Concepedia

Ruochen Dong

RD

Statistics

Publications

8

Citations

339

H-Index

8

Active since

2016

Affiliations

University of Kansas Medical Center(Current)

University of Kansas

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Ruochen Dong is an author at University of Kansas Medical Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2016–2022

8

Publications

8

High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study

Kishore Polireddy, Ruochen Dong, Gregory A. Reed et al. · Scientific Reports · 2017 · 146 citations · Full text

, , +15

An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells

Ruochen Dong, Ping Chen, Kishore Polireddy et al. · Molecular Cancer Therapeutics · 2020 · 59 citations · Full text

, , +17

Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study

Ping Chen, Greg Reed, Joyce Jiang et al. · Clinical Pharmacokinetics · 2022 · 34 citations · Full text

, , +13

IFT‐A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease

Wei Wang, Tana S. Pottorf, Henry H. Wang et al. · The Journal of Pathology · 2021 · 26 citations · Full text

, , +17

Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation

Kishore Polireddy, Ruochen Dong, Peter R. McDonald et al. · PLoS ONE · 2016 · 19 citations · Full text

, , +17

1–5 of 8